Close Menu

NEW YORK – Genome engineering firm Synthego said on Wednesday that it has raised $100 million in a Series D financing round.

The round was led by new investor Wellington Management, as well as by RA Capital Management and 8VC. Founders Fund, Menlo Ventures, and Intel Capital also participated, the company said, noting that this new round brings its total private funding raised to more than $250 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.